Semi-Annual Statement Of Income

Daito Pharmaceutical Co., Ltd. - Filing #7579309

Concept 2022-06-01 to
2022-11-30
2021-06-01 to
2021-11-30
Semi-annual statement of income
Statement of income
Net sales
23,367,000,000 JPY
22,463,000,000 JPY
Cost of sales
17,950,000,000 JPY
16,404,000,000 JPY
Ordinary profit (loss)
2,752,000,000 JPY
3,981,000,000 JPY
Gross profit (loss)
5,417,000,000 JPY
6,058,000,000 JPY
Extraordinary income
JPY
246,000,000 JPY
Selling, general and administrative expenses
2,590,000,000 JPY
2,181,000,000 JPY
Extraordinary losses
47,000,000 JPY
131,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
2,826,000,000 JPY
3,877,000,000 JPY
Profit (loss) before income taxes
2,705,000,000 JPY
4,096,000,000 JPY
Non-operating income
49,000,000 JPY
119,000,000 JPY
Non-operating income
Interest income
2,000,000 JPY
0 JPY
Dividend income
33,000,000 JPY
33,000,000 JPY
Non-operating expenses
123,000,000 JPY
14,000,000 JPY
Income taxes
981,000,000 JPY
1,335,000,000 JPY
Profit (loss)
1,724,000,000 JPY
2,760,000,000 JPY
Non-operating expenses
Interest expenses
7,000,000 JPY
4,000,000 JPY
Extraordinary income
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.